Changes in non-surgical management of stage III non-small cell lung cancer at a single institution between 2003 and 2010

References

• Aupérin A, Le Péchoux C, Rolland E, Curran WJ, Furuse K, Fournel P, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010;28:2181–90.
   PubMed Web of Science ®Google Scholar
• Curran WJ Jr, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, et al. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: Randomized phase III trial RTOG 9410. J Natl Cancer Inst 2011;103: 1452–60.
   PubMedGoogle Scholar
• Okawara G, Mackay JA, Evans WK, Ung YC, Lung cancer disease site group of cancer care Ontario’s program in evidence-based care. Management of unresected stage III non-small cell lung cancer: A systematic review. J Thorac Oncol 2006;1:377–93.
   PubMed Web of Science ®Google Scholar
• O’Rourke N, Roqué I, Figuls M, Farré Bernadó N, Macbeth F. Concurrent chemo-radiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 2010;6:CD002140.
   PubMedGoogle Scholar
• O’Rourke N, Macbeth F. Is concurrent chemoradiation the standard of care for locally advanced non-small cell lung cancer?. A review of guidelines and evidence. Clin Oncol 2010;22:347–55.
   Web of Science ®Google Scholar
• Van Meerbeeck JP, Koning CC, Tjan-Heijnen VC, Boekema AG, Kaandorp CJ, Burgers JS. [Guideline on non-small cell lung carcinoma; staging and treatment]. Ned Tijdschr Geneeskd 2005;149:72–7.
   PubMedGoogle Scholar
• Non-small cell lung cancer. National guideline The Netherlands. Integraal Kankercentrum Nederland, 2011. [cited 2012 Dec 23]. Available from: www.oncoline.nl/niet-kleincellig-longcarcinoom.
   Google Scholar
• Wouters MW, Siesling S, Jansen-Landheer ML, Elferink MA, Belderbos J, Coebergh JW, et al. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands. Eur J Surg Oncol 2010;36:83–92.
   PubMedGoogle Scholar
• Vinod SK, Wai E, Alexander C, Tyldesley S, Murray N. Stage III non-small-cell lung cancer: Population-based patterns of treatment in British Columbia, Canada. J Thorac Oncol 2012;7:1155–63.
   PubMed Web of Science ®Google Scholar
• Phernambucq EC, Spoelstra FO, Verbakel WF, Postmus PE, Melissant CF, Maassen van den Brink KI, et al. Outcomes of concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer and significant comorbidity. Ann Oncol 2011;22:132–8.
   PubMed Web of Science ®Google Scholar
• Underberg RW, Lagerwaard FJ, Cuijpers JP, Slotman BJ, van Sörnsen de Koste JR, Senan S. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int J Radiat Oncol Biol Phys 2004;60: 1283–90.
   PubMed Web of Science ®Google Scholar
• Underberg RW, van Sörnsen de Koste JR, Lagerwaard FJ, Vincent A, Slotman BJ, Senan S. A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer. Radiat Oncol 2006;1:8.
   PubMed Web of Science ®Google Scholar
• Verbakel WF, van Reij E, Ladenius-Lischer I, Cuijpers JP, Slotman BJ, Senan S. Clinical application of a novel hybrid intensity-modulated radiotherapy technique for stage III lung cancer and dosimetric comparison with four other techniques. Int J Radiat Oncol Biol Phys 2012;83: 297–303.
   PubMed Web of Science ®Google Scholar
• Wiersma TG, Dahele M, Verbakel WF, van de Ven PM, de Haan PF, Smit EF, et al. Concurrent chemoradiotherapy for large-volume locally-advanced non-small cell lung cancer. Lung Cancer 2013;80:62–7.
   PubMed Web of Science ®Google Scholar
• Van der Drift MA, Karim-Kos HE, Siesling S, Groen HJ, Wouters MW, Coebergh JW, et al. Progress in standard of care therapy and modest survival benefits in the treatment of non-small cell lung cancer patients in the Netherlands in the last 20 years. J Thorac Oncol 2012;7: 291–8.
   PubMed Web of Science ®Google Scholar
• Lee JH, Wu HG, Kim HJ, Kim DW, Lee SH, Kim TM, et al. Influence of comorbidities on the efficacy of radiotherapy with or without chemotherapy in elderly stage III non- small cell lung cancer patients. Cancer Res Treat 2012;44: 242–50.
   PubMedGoogle Scholar
• Kang KM, Jeong BK, Ha IB, Chai GY, Lee GW, Kim HG, et al. Concurrent chemoradiotherapy for elderly patients with stage III non-small cell lung cancer. Radiat Oncol J 2012;30:140–5.
   PubMedGoogle Scholar
• Cox JD. Are the results of RTOG 0617 mysterious?. Int J Radiat Oncol Biol Phys 2012;82:1042–4.
   PubMed Web of Science ®Google Scholar
• Liao ZX, Komaki RR, Thames HD Jr, Liu HH, Tucker SL, Mohan R, et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys 2010; 76:775–81.
   PubMed Web of Science ®Google Scholar
• Komaki R, Khalid N, Langer CJ, Spring Kong FM, Owen JB, Crozier CL, et al. Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: A quality research in radiation oncology survey. Int J Radiat Oncol Biol Phys 2013; 85:1082–9.
   PubMed Web of Science ®Google Scholar